Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Fulcrum Therapeutics, Inc. (FULC)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 63,029,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases. Co. has developed a proprietary product engine, FulcrumSeek, that it employs to systematically identify and validate cellular drug targets. Co.' products include: losmapimod, a small molecule that it is developing for the treatment of facioscapulohumeral muscular dystrophy, a rare, progressive and disabling disorder characterized by muscle degeneration and fat infiltration; and FTX-6058, an investigational oral fetal hemoglobin, inducer that is in development for sickle cell disease and select other hemoglobinopathies, including ss-thalassemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 43,360 43,360 43,360 4,472,361
Total Buy Value $492,028 $492,028 $492,028 $39,173,214
Total People Bought 1 1 1 2
Total Buy Transactions 1 1 1 7
Total Shares Sold 5,120 5,120 5,120 150,153
Total Sell Value $59,050 $59,050 $59,050 $1,271,940
Total People Sold 1 1 1 2
Total Sell Transactions 2 2 2 8
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 122
  Page 3 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wallace Owen B. Chief Scientific Officer   •       –      –    2020-09-14 4 OE $7.84 $49,784 D/D 6,350 133,438     -
   Gould Robert J See Remarks   •       •      –    2020-07-08 4 AS $20.00 $50,000 D/D (2,500) 534,845     -
   Wallace Owen B. Chief Scientific Officer   •       –      –    2020-07-08 4 AS $20.00 $59,020 D/D (2,951) 127,088     -
   Wallace Owen B. Chief Scientific Officer   •       –      –    2020-07-08 4 OE $7.84 $23,136 D/D 2,951 130,039     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-07-01 4 AS $18.30 $19,599 D/D (1,071) 65,714     -
   Wallace Owen B. Chief Scientific Officer   •       –      –    2020-06-30 4 AS $20.00 $2,820 D/D (141) 127,088     -
   Wallace Owen B. Chief Scientific Officer   •       –      –    2020-06-30 4 OE $7.84 $1,105 D/D 141 127,229     -
   Gould Robert J See Remarks   •       •      –    2020-06-25 4 AS $20.80 $51,992 D/D (2,500) 537,345     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-25 4 AS $22.00 $32,098 D/D (1,459) 66,785     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-25 4 OE $4.83 $7,047 D/D 1,459 68,244     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-10 4 AS $22.00 $8,822 D/D (401) 66,785     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-10 4 OE $4.83 $1,937 D/D 401 67,186     -
   Gould Robert J See Remarks   •       •      –    2020-06-09 4 AS $20.00 $3,120 D/D (156) 539,845     -
   Gould Robert J See Remarks   •       •      –    2020-06-05 4 AS $20.17 $69,251 D/D (3,433) 540,001     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-05 4 AS $20.18 $9,101 D/D (451) 66,785     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-05 4 OE $4.83 $2,178 D/D 451 67,236     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-04 4 AS $20.05 $4,531 D/D (226) 66,785     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-04 4 OE $4.83 $1,092 D/D 226 67,011     -
   Gould Robert J See Remarks   •       •      –    2020-06-04 4 AS $20.04 $26,058 D/D (1,300) 543,434     -
   Gould Robert J See Remarks   •       •      –    2020-06-03 4 AS $20.13 $30,192 D/D (1,500) 544,734     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-03 4 AS $20.18 $6,820 D/D (338) 66,785     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-03 4 OE $4.83 $1,633 D/D 338 67,123     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-02 4 AS $20.00 $900 D/D (45) 66,785     -
   Cadavid Diego SVP Clinical Development   •       –      –    2020-06-02 4 OE $4.83 $217 D/D 45 66,830     -
   Gould Robert J See Remarks   •       •      –    2020-06-02 4 AS $20.00 $55,940 D/D (2,797) 546,234     -
  122 Records found
  1  2  3  4  5   
  Page 3 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us